Why is accessibility such a crucial consideration of open access publishing, and how can we ensure content is sufficiently accessible?
Publishing open access saves lives: policies and barriers
How have policies and mandates helped shape open access publishing, and what barriers exist that slow their implementation?
Publishing open access saves lives: equity and benefits
What are the benefits of open access publishing, and how can we improve equity in academic and medical communications?
In case you missed it – publishing open access saves lives
To celebrate Open Access Week 2020, Open Pharma teamed up with NetworkPharma and MedComms Networking to host an expert panel discussion on multi-stakeholder perspectives on open access publishing of pharma-sponsored research.
Using publication plain language summaries to inform and empower patients, caregivers and non-specialists
Is it not ironic that the scientific community often fails to recognize the public in publications?
Publishing open access saves lives
During Open Access Week 2020 and one year after the launch of the Open Pharma position statement on open access, we bring together stakeholders from different backgrounds to share their perspectives on open access publishing of pharma-sponsored research.
What medical communications has taught me that academia didn’t
One month into my role at Oxford PharmaGenesis has taught me more about scientific and medical publishing than 6 years in the world of academic research. Here, I discuss some of the key issues around academic publishing, and how some researchers in academia could learn from best practices developed to ensure compliance, transparency and integrity in the medical communications industry.
Evidence-based medicine no more?
In a pre-COVID-19 world, this week would have seen evidence-based medicine experts gather in Toronto for EBM Live 2020. However, like many other meetings during the pandemic, it has been postponed. Here, I reflect on last year’s meeting and pharma’s journey in improving the reporting of clinical trials.
Reproducible research and industry partnership jointly generate high-impact scientific discoveries
The hallmarks of sound science are reproducibility and generalizability that have been subjected to scientific peer review. If any of these characteristics is missing, science is lost. It sounds very simple, but anomalies and deficiencies are everywhere.
Ways to increase transparency, trust and patient involvement in pharma-funded publications – insights from the virtual 16th Annual Meeting of ISMPP
This year, the Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) went virtual. With a mix of engaging live and recorded sessions, 15 roundtables and over 45 posters to delve into, we share some of the highlights from the meeting.